CME/CE

586-600 of 921

• 

  RestartResume

  First-Line Advanced Gastric Cancer: Best Practices for Biomarker-Directed Treatment Approaches—A Case Study   

  MinuteCE®

  First-Line Advanced Gastric Cancer: Best Practices for Biomarker-Directed Treatment Approaches—A Case Study   

  • 

    

    Sara Lonardi, MD

    Peer

  1.25 program credits

• 

  RestartResume

  Immunotherapy-Based Approaches for First-Line Treatment of Advanced HCC: The Evidence  

  MinuteCE®

  Immunotherapy-Based Approaches for First-Line Treatment of Advanced HCC: The Evidence  

  • 

    

    Alan Venook, MD

    Peer

  1.25 program credits

• 

  RestartResume

  First-line Treatment of MSI-H/dMMR mCRC: The Role of Immunotherapy

  MinuteCE®

  First-line Treatment of MSI-H/dMMR mCRC: The Role of Immunotherapy

  • 

    

    Aparna R. Parikh, MD

    Peer

  1.25 program credits

• 

  RestartResume

  Current Guideline Recommendations for Biomarker-Based Second-Line Treatment of mCRC

  MinuteCE®

  Current Guideline Recommendations for Biomarker-Based Second-Line Treatment of mCRC

  • 

    

    Aparna R. Parikh, MD

    Peer

  1.25 program credits

• 

  RestartResume

  Applying Current Guidelines in the First-Line Treatment of MSI-H/dMMR mCRC—A Case Discussion

  MinuteCE®

  Applying Current Guidelines in the First-Line Treatment of MSI-H/dMMR mCRC—A Case Discussion

  • 

    

    Aparna R. Parikh, MD

    Peer

  1.25 program credits

• 

  RestartResume

  Emerging Directions in Biomarker-Directed Therapy for GI Malignancies

  MinuteCE®

  Emerging Directions in Biomarker-Directed Therapy for GI Malignancies

  • 

    

    Alan Venook, MD

    Peer

  1.25 program credits
• advertisement

• 

  RestartResume

  Novel Neoadjuvant and Adjuvant Immunotherapy Strategies for GI Malignancies: The Evidence   

  MinuteCE®

  Novel Neoadjuvant and Adjuvant Immunotherapy Strategies for GI Malignancies: The Evidence   

  • 

    

    Alan Venook, MD

    Peer

  1.25 program credits

• 

  RestartResume

  Expert Opinion: Key Insights on GI Malignancies—Integrating NCCN Clinical Practice Guidelines Into Practice

  MinuteCE®

  Expert Opinion: Key Insights on GI Malignancies—Integrating NCCN Clinical Practice Guidelines Into Practice

  • 

    

    Sara Lonardi, MD

    Peer

  • 

    

    Aparna R. Parikh, MD

    Peer

  • 

    

    Alan Venook, MD

    Peer

  1.25 program credits

• 

  MinuteCE®

  Innovations in Oncology Learning Center From Guidelines to Practice: Genitourinary Cancers

  • 

    

    Ignacio Duran, MD

    Peer

  • 

    

    Wenxin Xu, MD

    Peer

  • 

    

    Sandy Srinivas, MD

    Peer

  1.25 credits 10 episodes

• 

  RestartResume

  Risk Assessment in Pulmonary Hypertension: Practice Trends and Updates

  CME/CE Broadcast Replay

  Risk Assessment in Pulmonary Hypertension: Practice Trends and Updates

  • 

    

    Robert P. Frantz, MD, FACC

    Peer

  • 

    

    Vallerie V. McLaughlin, MD

    Peer

  • 

    

    Sonja Bartolomei, MD

    Peer

  1.00 credits

• 

  RestartResume

  Pulmonary Hypertension Management: Practice Trends and Updates

  CME/CE Broadcast Replay

  Pulmonary Hypertension Management: Practice Trends and Updates

  • 

    

    Vallerie V. McLaughlin, MD

    Peer

  • 

    

    Victor Moles, MD

    Peer

  • 

    

    Ioana Preston, MD

    Peer

  1.00 credits

• 

  RestartResume

  Pulmonary Hypertension: Comorbidities With PAH and Group 2 PH 

  CME/CE Broadcast Replay

  Pulmonary Hypertension: Comorbidities With PAH and Group 2 PH 

  • 

    

    Vallerie V. McLaughlin, MD

    Peer

  • 

    

    Thomas Cascino, MD

    Peer

  • 

    

    Bradley A. Maron, MD

    Peer

  1.00 credits
• advertisement

• 

  MinuteCE®

  Innovations in Oncology Learning Center From Guidelines to Practice: Gynecologic Cancer

  • 

    

    Susana Campos, MD, MPH

    Peer

  • 

    

    Nicoletta Colombo, MD

    Peer

  • 

    

    Ritu Salani, MD, MBA

    Peer

  1.00 credits 10 episodes

• 

  RestartResume

  Clinical evidence driving guideline recommendations for frontline immunotherapy-based combination regimens in metastatic urothelial cancer

  MinuteCE®

  Clinical evidence driving guideline recommendations for frontline immunotherapy-based combination regimens in metastatic urothelial cancer

  • 

    

    Ignacio Duran, MD

    Peer

  • 

    

    Wenxin Xu, MD

    Peer

  1.25 program credits

• 

  RestartResume

  Clinical evidence driving guideline recommendations for monotherapy in the second-line or later setting in metastatic urothelial cancer

  MinuteCE®

  Clinical evidence driving guideline recommendations for monotherapy in the second-line or later setting in metastatic urothelial cancer

  • 

    

    Ignacio Duran, MD

    Peer

  • 

    

    Sandy Srinivas, MD

    Peer

  1.25 program credits

• Prev
• 1
• 2
• …
• 38
• 39
• 40
• 41
• 42
• …
• 61
• 62
• Next